reglab/statecodes huggingface dataset:
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.12 | Licenses; Renewal.

Effective:
April 6, 2023
Latest Legislation:
House Bill 509 - 134th General Assembly
A license issued by the state board of pharmacy under section 4729.08 or 4729.11 of the Revised Code entitles the individual to whom it is issued to practice as a pharmacist or as a pharmacy intern in this state until the next renewal date.
Licenses shall be renewed according to the standard renewal procedure of Chapter 4745. of the Revised Code and rules adopted by the board under section 4729.26 of the Revised Code. Licenses are valid for the period specified in the rules, unless earlier revoked or suspended by the board. The period shall not exceed twenty-four months unless the board extends the period in the rules to adjust license renewal schedules.
A pharmacist or pharmacy intern who desires to continue in the practice of pharmacy shall file with the board an application in such form and containing such data as the board may require for renewal of a license. In the case of a pharmacist who dispenses or plans to dispense controlled substances in this state, the pharmacist shall certify, as part of the application, that the pharmacist has been granted access to the drug database established and maintained by the board pursuant to section 4729.75 of the Revised Code, unless the board has restricted the pharmacist from obtaining further information from the database or the board no longer maintains the database. If the pharmacist certifies to the board that the applicant has been granted access to the drug database and the board finds through an audit or other means that the pharmacist has not been granted access, the board may take action under section 4729.16 of the Revised Code.
An application filed under this section for renewal of a license may not be withdrawn without the approval of the board.
The board shall renew an applicant's license if the board finds all of the following:
(A) The applicant's license has not been revoked or placed under suspension.
(B) The applicant has paid the renewal fee.
(C) If the applicant is a pharmacist, the applicant has completed thirty hours of continued pharmacy education in the previous two years in accordance with any rules of the board.
(D) The applicant is entitled to continue in the practice of pharmacy.
When a license has expired but an application is made within three years after the expiration of the license, the applicant's license shall be renewed without further examination if the applicant meets the requirements of this section and pays the fee designated under division (A)(5) of section 4729.15 of the Revised Code.
A pharmacist or pharmacy intern who fails to renew the pharmacist's or intern's license by the renewal date prescribed by the board shall not engage in the practice of pharmacy until a valid license is issued by the board.
Last updated March 22, 2023 at 12:22 PM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.13 | Failure to Renew License.

Effective:
September 29, 2017
Latest Legislation:
House Bill 49 - 132nd General Assembly
A pharmacist who fails to make application to the state board of pharmacy for a license renewal within a period of three years from the expiration of the license must pass an examination for licensure and comply with sections 4776.01 to 4776.04 of the Revised Code; except that a pharmacist whose license has expired, but who has continually practiced pharmacy in another state under a license issued by the authority of that state, may obtain a renewed license upon payment to the executive director of the board the fee designated under division (A)(6) of section 4729.15 of the Revised Code.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.162 | Adoption of Rules Regarding Review of Patient Information Available Through Drug Database.

Effective:
March 13, 2013
Latest Legislation:
Senate Bill 301 - 129th General Assembly
(A) As used in this section, "drug database" means the database established and maintained by the state board of pharmacy pursuant to section 4729.75 of the Revised Code.
(B) The state board of pharmacy shall adopt rules in accordance with Chapter 119. of the Revised Code that establish standards and procedures to be followed by a pharmacist regarding the review of patient information available through the drug database under division (A)(6) of section 4729.80 of the Revised Code.
(C) This section and the rules adopted under it do not apply if the board no longer maintains the drug database.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.17 | Single Member May Hold Hearing.

Effective:
August 30, 2007
Latest Legislation:
Senate Bill 58 - 127th General Assembly
Any investigation, inquiry, or hearing, which the state board of pharmacy is empowered to hold or undertake may be held or undertaken by or before any member or members of the board and the finding or order of such member or members shall be deemed to be the order of said board when approved and confirmed by a majority of the board members present and voting at a meeting of the board at which there is a quorum.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.171 | Designation of Hearing Examiners.

Effective:
April 6, 2017
Latest Legislation:
Senate Bill 319 - 131st General Assembly
(A)(1)(a) The state board of pharmacy may designate one or more attorneys at law who have been admitted to the practice of law, and who are classified as either administrative law attorney examiners or as administrative law attorney examiner administrators under the state job classification plan adopted under section 124.14 of the Revised Code, as hearing examiners, subject to Chapter 119. of the Revised Code, to conduct any hearing the board is empowered to hold or undertake pursuant to Chapter 119. of the Revised Code.
(b) Notwithstanding the requirement of division (A)(1)(a) of this section that the board designate as a hearing examiner an attorney who is classified as either an administrative law attorney examiner or an administrative law attorney examiner administrator, the board may, subject to section 127.16 of the Revised Code, enter into a personal service contract with an attorney admitted to the practice of law in this state to serve as a hearing examiner.
(2) The hearing examiner shall hear and consider the oral and documented evidence introduced by the parties and issue in writing proposed findings of fact and conclusions of law to the board for their consideration within thirty days following the close of the hearing.
(B) The board shall be given copies of the transcript of the hearing record and all exhibits and documents presented by the parties at the hearing.
(C) The board shall render a decision and take action within ninety days following the receipt of the hearing examiner's proposed findings of fact and conclusions of law.
(D) The final decision of the board in any hearing shall be in writing and contain findings of fact and conclusions of law. Copies of the decision shall be delivered to the parties personally or by certified mail. The decision is final on delivery or mailing, but may be appealed as provided by Chapter 119. of the Revised Code.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.19 | Cooperation in Investigation.

Effective:
March 22, 2019
Latest Legislation:
Senate Bill 229 - 132nd General Assembly
Notwithstanding division (B)(4) of section 2317.02 of the Revised Code, a pharmacist, pharmacy intern, pharmacy technician trainee, registered pharmacy technician, certified pharmacy technician, terminal distributor of dangerous drugs, manufacturer of dangerous drugs, outsourcing facility, third-party logistics provider, repackager of dangerous drugs, or wholesale distributor of dangerous drugs shall cooperate with federal, state, and local government investigations and shall divulge all relevant information when requested by a government agency.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.20 | Dispensing for Purposes of Medication Synchronization.

Effective:
August 31, 2016
Latest Legislation:
House Bill 116 - 131st General Assembly
As used in this section, "medication synchronization" means a pharmacy service that synchronizes the filling or refilling of prescriptions in a manner that allows the dispensed drugs to be obtained on the same date each month.
A pharmacist may dispense a drug in a manner that varies from the prescription for the drug by dispensing a quantity or amount of the drug that is less than a thirty-day supply, if the pharmacist's action is taken solely for the purpose of medication synchronization pursuant to section 1751.68, 3923.602, 5164.7511, or 5167.12 of the Revised Code.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.23 | Confidential Information; Investigations and Inspections.

Effective:
April 8, 2019
Latest Legislation:
House Bill 101 - 132nd General Assembly
(A) Except as provided in division (B) of this section, information received by the state board of pharmacy pursuant to an investigation is confidential, is not a public record, and is not subject to discovery in any civil action.
(B) The board shall conduct all investigations or inspections and proceedings in a manner that protects the confidentiality of patients, confidential informants, and individuals who file complaints with the board. The board shall not make public the names or any other identifying information of patients, confidential informants, or complainants unless proper consent is given or, in the case of a patient, a waiver of the patient privilege exists under division (B) of section 2317.02 of the Revised Code. The consent or waiver is not required if the board possesses reliable and substantial evidence that no bona fide physician-patient relationship exists.
On request, the board may share any information it receives pursuant to an investigation or inspection, including patient records and patient record information, with law enforcement agencies, other licensing boards, and other state or federal governmental agencies that are prosecuting, adjudicating, or investigating alleged violations of statutes or administrative rules. An agency or board that receives the information shall comply with the same requirements regarding confidentiality as those with which the state board of pharmacy must comply, notwithstanding any conflicting provision of the Revised Code or agency procedure that applies when the agency is dealing with other information in its possession.
Any information the board receives from a state or federal agency is subject to the same confidentiality requirements as the agency from which it was received and shall not be released by the board without prior authorization from that agency.
The board may, for good cause shown, disclose or authorize disclosure of information gathered pursuant to an investigation.
(C) Any board activity that involves continued monitoring of an individual for treatment or recovery purposes as part of or following any disciplinary action taken under this chapter shall be conducted in a manner that maintains an individual's confidentiality with respect to the individual's treatment or recovery program. Information received or maintained by the board with respect to the board's monitoring activities is not subject to discovery in any civil action, is not a public record, and is confidential, except that the board may disclose information to law enforcement officers and government entities for purposes of an investigation of a license or certificate holder.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.24 | Authority of Board to Take Depositions, Issue Subpoenas, Etc.

Effective:
September 29, 2017
Latest Legislation:
House Bill 49 - 132nd General Assembly
(A) Subject to division (B) of this section, in addition to the actions the state board of pharmacy may take under Chapter 119. of the Revised Code, the board may order the taking of depositions; examine and copy any books, accounts, papers, records, documents, and other tangible objects; issue subpoenas; and compel the attendance of witnesses and production of books, accounts, papers, records, documents, and other tangible objects.
On failure of a person to comply with a subpoena issued by the board and after reasonable notice to that person, the board may apply to the court of common pleas of Franklin county for an order compelling the production of persons or records pursuant to the Ohio Rules of Civil Procedure.
A subpoena issued by the board may be served by a sheriff, sheriff's deputy, or board employee designated by the board. Service of a subpoena may be made by delivering a copy of the subpoena to the person named in the subpoena or by leaving it at the person's usual place of residence.
(B) A subpoena for patient record information may be issued only on approval by the board's executive director and the president or another board member designated by the president, in consultation with the office of the attorney general. Before issuing the subpoena, the executive director and the office of the attorney general shall determine whether probable cause exists to believe that the complaint filed alleges, or an investigation has revealed, a violation of this chapter or Chapters 2925., 3715., 3719., or 3796. of the Revised Code or any rule adopted by the board, that the records sought are relevant to the alleged violation and material to the investigation, and that the records cover a reasonable period of time surrounding the alleged violation.
(C) The board may adopt rules in accordance with Chapter 119. of the Revised Code establishing procedures to be followed in taking the actions authorized by this section, including procedures regarding payment for and service of subpoenas.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.25 | Enforcement.

Effective:
May 18, 2005
Latest Legislation:
House Bill 377 - 125th General Assembly
(A) The state board of pharmacy shall enforce, or cause to be enforced, this chapter. If it has information that any provision of this chapter has been violated, it shall investigate the matter, and take such action as it considers appropriate.
(B) Nothing in this chapter shall be construed to require the state board of pharmacy to enforce minor violations of this chapter if the board determines that the public interest is adequately served by a notice or warning to the alleged offender.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.26 | Administrative Rules.

Effective:
May 18, 2005
Latest Legislation:
House Bill 377 - 125th General Assembly
The state board of pharmacy may adopt rules in accordance with Chapter 119. of the Revised Code, not inconsistent with the law, as may be necessary to carry out the purposes of and to enforce the provisions of this chapter. The rules shall be published and made available by the board to each pharmacist licensed under this chapter.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.27 | Pharmacist Must Be in Full and Actual Charge of Pharmacy.

Effective:
July 22, 1998
Latest Legislation:
Senate Bill 66 - 122nd General Assembly
A person not a pharmacist, who owns, manages, or conducts a pharmacy, shall employ a pharmacist to be in full and actual charge of such pharmacy. Any pharmacist who owns, manages, or conducts a pharmacy shall be personally in full and actual charge of the pharmacy, or shall employ another pharmacist to be in full and actual charge of the pharmacy.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.28 | Unauthorized Practice.

Effective:
April 6, 2023
Latest Legislation:
House Bill 558 - 134th General Assembly
(A) As used in this section, "dispense" has the meaning specified by the state board of pharmacy in rules adopted under section 4729.26 of the Revised Code.
(B)(1) Except as provided in division (B)(2) of this section, no person who is not a pharmacist or a pharmacy intern under the personal supervision of a pharmacist shall compound or sell dangerous drugs or otherwise engage in the practice of pharmacy.
(2) Except as provided in section 3701.048 of the Revised Code with respect to other health care professionals, in sections 3715.512 and 4729.47 of the Revised Code with respect to pharmacy interns, or in rules adopted by the board under section 4729.26 of the Revised Code, no person who is not a pharmacist shall dispense dangerous drugs.
Last updated March 15, 2023 at 12:49 PM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.282 | Dispensing of Drugs Pursuant to Prescriptions Made Without Examination and Ept Prescriptions.

Effective:
March 23, 2016
Latest Legislation:
House Bill 124 - 131st General Assembly
(A) Notwithstanding any conflicting provision of this chapter or rule adopted by the state board of pharmacy, a pharmacist may do both of the following with respect to a prescription issued under section 4723.4810, 4730.432, or 4731.93 of the Revised Code:
(1) Dispense a drug pursuant to the prescription ;
(2) Label a drug dispensed pursuant to the prescription without the name of the individual for whom the drug is intended if the prescription contains the words "expedited partner therapy" or the letters "EPT."
(B) For each drug dispensed under this section, the pharmacist shall provide all of the following information:
(1) Directions for use of the drug;
(2) Any side effects, adverse reactions, or known contraindications associated with the drug.
(C) A pharmacist who in good faith dispenses a drug under this section is not liable for or subject to any of the following:
(1) Damages in any civil action;
(2) Prosecution in any criminal proceeding;
(3) Professional disciplinary action.
(D) This section does not affect the authority of a pharmacist to distribute information concerning a drug as required by federal law.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.283 | Dispensing Naltrexone Without Prescription.

Effective:
June 1, 2022
Latest Legislation:
House Bill 37 - 134th General Assembly
(A) A pharmacist may dispense naltrexone without a prescription from a licensed health professional authorized to prescribe drugs if all of the following conditions are met:
(1) The pharmacist is able to verify a record of a prescription for the injectable long-acting or extended-release form of naltrexone in the name of the patient who is requesting the drug, but the prescription does not provide for a refill or the time permitted by rules adopted by the state board of pharmacy for providing refills has elapsed.
(2) The pharmacist is unable to obtain authorization to refill the prescription from the prescriber who issued it or another prescriber responsible for the patient's care.
(3) In the exercise of professional judgment, the pharmacist determines that both of the following are the case:
(a) The drug is necessary to continue the patient's therapy for substance use disorder.
(b) Failure to dispense the drug to the patient could result in harm to the health of the patient.
(B) Before dispensing naltrexone under this section, the pharmacist shall offer the patient the choice of receiving either the oral form or injectable long-acting or extended-release form, but only if both forms of the drug are available for dispensing at the time of the patient's request or within one day after the request.
(C)(1) With respect to naltrexone dispensed in an oral form under this section, the pharmacist shall not dispense an amount that exceeds a five-day supply.
(2) With respect to naltrexone dispensed in an injectable long-acting or extended-release form under this section, both of the following apply:
(a) The pharmacist shall exercise professional judgment in determining the amount of the drug dispensed.
(b) The pharmacist may administer the drug by injection to the patient but only in accordance with section 4729.45 of the Revised Code.
(D) A pharmacist who dispenses naltrexone under this section shall do all of the following:
(1) For one year after the date of dispensing, maintain a record in accordance with this chapter of the drug dispensed, including the amount and form dispensed, the original prescription number, the name and address of the patient, and, if the individual receiving the drug is not the patient, the name and address of that individual;
(2) Notify the prescriber who issued the original prescription or another prescriber responsible for the patient's care not later than five days after the drug is dispensed;
(3) If applicable, obtain authorization for additional dispensing from one of the prescribers described in division (D)(2) of this section.
(E) A pharmacist shall exercise professional judgment in determining the number of times naltrexone may be dispensed under this section to the same patient.
(F) This section does not limit the authority of a pharmacist to dispense a dangerous drug under section 4729.281 of the Revised Code.
Last updated March 9, 2022 at 4:00 PM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.285 | Telehealth Services.

Effective:
March 23, 2022
Latest Legislation:
House Bill 122 - 134th General Assembly
A pharmacist may provide telehealth services in accordance with section 4743.09 of the Revised Code, except that in the case of dispensing a dangerous drug, a pharmacist shall not use telehealth mechanisms or other virtual means to perform any of the actions involved in dispensing the dangerous drug unless the action is authorized by the state board of pharmacy through rules it adopts under this chapter or section 4743.09 of the Revised Code.
Last updated January 27, 2022 at 3:20 PM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.29 | Exemptions.

Effective:
April 6, 2023
Latest Legislation:
House Bill 558 - 134th General Assembly
Divisions (A) and (B) of section 4729.01 and section 4729.28 of the Revised Code do not do any of the following:
(A) Apply to a licensed health professional authorized to prescribe drugs who is acting within the prescriber's scope of professional practice;
(B) Prevent a prescriber from personally furnishing the prescriber's patients with drugs, within the prescriber's scope of professional practice, that seem proper to the prescriber, as long as the drugs are furnished in accordance with section 4729.291 of the Revised Code;
(C) Apply to an individual who personally furnishes a supply of overdose reversal drugs under the authority conferred by section 3715.50 of the Revised Code or prevent an individual from personally furnishing a supply of overdose reversal drugs in accordance with a protocol established under section 3715.503 of the Revised Code;
(D) Apply to the sale of oxygen, the sale of peritoneal dialysis solutions, or the sale of drugs that are not dangerous drugs by a retail dealer, in original packages when labeled as required by the "Federal Food, Drug, and Cosmetic Act," 52 Stat. 1040 (1938), 21 U.S.C.A. 301, as amended.
Last updated January 24, 2023 at 9:33 AM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.291 | Drugs Personally Furnished by Prescriber.

Effective:
April 12, 2021
Latest Legislation:
Senate Bill 260 - 133rd General Assembly
(A) Except when provided under section 4731.97 of the Revised Code, when a licensed health professional authorized to prescribe drugs personally furnishes drugs to a patient pursuant to division (B) of section 4729.29 of the Revised Code, the prescriber shall ensure that the drugs are labeled and packaged in accordance with state and federal drug laws and any rules and regulations adopted pursuant to those laws. Records of purchase and disposition of all drugs personally furnished to patients shall be maintained by the prescriber in accordance with state and federal drug statutes and any rules adopted pursuant to those statutes.
(B) When personally furnishing to a patient RU-486 (mifepristone), a prescriber is subject to sections 2919.123 and 2919.124 of the Revised Code.
(C)(1) Except as provided in divisions (D) and (E) of this section, no prescriber shall do either of the following:
(a) In any thirty-day period, personally furnish to or for patients, taken as a whole, controlled substances in an amount that exceeds a total of two thousand five hundred dosage units;
(b) In any seventy-two-hour period, personally furnish to or for a patient an amount of a controlled substance that exceeds the amount necessary for the patient's use in a seventy-two-hour period.
(2) The state board of pharmacy may impose a fine of not more than five thousand dollars on a prescriber who fails to comply with the limits established under division (C)(1) of this section. A separate fine may be imposed for each instance of failing to comply with the limits. In imposing the fine, the board's actions shall be taken in accordance with Chapter 119. of the Revised Code.
(D) None of the following shall be counted in determining whether the amounts specified in division (C)(1) of this section have been exceeded:
(1) Methadone personally furnished to patients for the purpose of treating drug dependence or addiction, if the prescriber meets the conditions specified in 21 C.F.R. 1306.07;
(2) Buprenorphine personally furnished to patients for the purpose of treating drug dependence or addiction as part of an opioid treatment program licensed under section 5119.37 of the Revised Code.
(3) Controlled substances personally furnished to research subjects by a facility conducting clinical research in studies approved by a hospital-based institutional review board or an institutional review board accredited by the association for the accreditation of human research protection programs.
(E) Division (C)(1) of this section does not apply to a prescriber who is a veterinarian.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.292 | On-Site Inspection of Opioid Treatment Programs.

Effective:
June 29, 2019
Latest Legislation:
House Bill 111 - 132nd General Assembly
The state board of pharmacy shall annually conduct an on-site inspection of each opioid treatment program licensed under section 5119.37 of the Revised Code.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.30 | Sale of Paris Green.

Effective:
July 22, 1998
Latest Legislation:
Senate Bill 66 - 122nd General Assembly
Sections 4729.27 and 4729.28 of the Revised Code shall not prohibit a person from selling Paris green and other materials or compounds used exclusively for spraying and disinfecting when put up in bottles or boxes, bearing the name of a licensed pharmacist or wholesale dealer, and labeled as required by section 3719.33 of the Revised Code or apply to or interfere with the exclusively wholesale business of a dealer.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.31 | Exceptions.

Effective:
October 1, 1953
Latest Legislation:
House Bill 1 - 100th General Assembly
Sections 4729.27 and 4729.28 of the Revised Code shall not apply to, interfere with, or prohibit any person, firm, or corporation from selling completely denatured alcohol or wood alcohol.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.32 | Requirements for Sale of Denatured or Wood Alcohol in Five Gallon Lots or More.

Effective:
October 1, 1953
Latest Legislation:
House Bill 1 - 100th General Assembly
No person shall have in his possession, or dispense or sell packages or containers of completely denatured alcohol or wood alcohol containing five wine gallons or more without having marked or stenciled thereon the name and address of the seller, the degree of proof of such alcohol, the formula number, and, in letters of not less than one inch in height, the words, "Completely Denatured Alcohol" or "Wood Alcohol," as the case may be, and the names of two or more antidotes for the same. This section, and sections 4729.33 and 3719.33 of the Revised Code shall not interfere with the transfer of such alcohol from storage tanks to other packages or containers, nor require the placing of such mark or stencil upon transportation tanks, nor the registration or placing of mark or stencil upon fuel tanks, automobile radiators, or similar containers for the final use or consumption of such alcohol and from which no further distribution thereof is made.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.33 | Requirements for Sale of Denatured or Wood Alcohol in Less Than Five Gallon Lots.

Effective:
October 1, 1953
Latest Legislation:
House Bill 1 - 100th General Assembly
No person shall dispense or sell completely denatured alcohol or wood alcohol in packages containing less than five wine gallons without having affixed thereto a label on which is printed or stenciled in plain, legible, red letters of equal prominence on a white background the words, "Completely Denatured Alcohol" or "Wood Alcohol," as the case may be, and in addition on the same label in red ink, under the skull and crossbones symbol, the word "POISON" together with the following statement: "Completely denatured alcohol, or wood alcohol is a violent poison. It cannot be applied externally to human or animal tissue without serious injurious results. It cannot be taken internally without inducing blindness and general physical decay ultimately resulting in death," and without having stamped, stenciled, or printed upon such label the name and address of the seller, the degree of proof, and the formula number thereof. Neither the word "pure" nor the single word "alcohol" alone shall appear on any label of completely denatured alcohol or wood alcohol.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.34 | Advertising.

Effective:
October 1, 1953
Latest Legislation:
House Bill 1 - 100th General Assembly
No person shall dispense, sell, or offer for sale completely denatured alcohol or wood alcohol, or shall display a sign or use a label or advertise such alcohol having the word "pure" or the single word "alcohol" alone thereon, or shall fail to state the degree of proof of such alcohol, or to have the letters displaying or advertising "Completely Denatured Alcohol" or "Wood Alcohol" plain, legible, and of equal prominence.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.35 | Violations Deemed Public Nuisance.

Effective:
September 20, 1984
Latest Legislation:
House Bill 208 - 115th General Assembly
The violation by a pharmacist or other person of any laws of Ohio or of the United State of America or of any rule of the board of pharmacy controlling the distribution of a drug of abuse as defined in section 3719.011 of the Revised Code or the commission of any act set forth in division (A) of section 4729.16 of the Revised Code, is hereby declared to be inimical, harmful, and adverse to the public welfare of the citizens of Ohio and to constitute a public nuisance. The attorney general, the prosecuting attorney of any county in which the offense was committed or in which the person committing the offense resides, or the state board of pharmacy may maintain an action in the name of the state to enjoin such person from engaging in such violation. Any action under this section shall be brought in the common pleas court of the county where the offense occurred or the county where the alleged offender resides.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.36 | Advertisements.

Effective:
July 22, 1998
Latest Legislation:
Senate Bill 66 - 122nd General Assembly
(A) No place except a pharmacy licensed as a terminal distributor of dangerous drugs and no person except a licensed pharmacist shall display any sign or advertise in any fashion, using the words "pharmacy," "drugs," "drug store," "drug store supplies," "pharmacist," "druggist," "pharmaceutical chemist," "apothecary," "drug sundries," "medicine," or any of these words or their equivalent, in any manner.
(B) A pharmacy making retail sales may advertise by name or therapeutic class the availability for sale or dispensing of any dangerous drug provided that the advertising includes the price information specified in the definition of that term in section 4729.01 of the Revised Code.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.361 | Disclosing Price Information.

Effective:
October 1, 1976
Latest Legislation:
House Bill 912 - 111th General Assembly
(A) A retail seller of dangerous drugs shall disclose price information regarding dangerous drugs to any person requesting such information.
(B) Pursuant to division (A) of this section, a retail seller of dangerous drugs shall disclose price information in the following ways:
(1) By means of verbal disclosure on the premises of the retail seller to all persons requesting such information;
(2) By means of telephone to any person having a valid prescription, who identifies himself and requests such information.
(C) Price disclosure shall not be required for those schedule II controlled substances where lives or property could be endangered by such disclosure.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.37 | Filling Prescriptions - Records.

Effective:
July 22, 1998
Latest Legislation:
Senate Bill 66 - 122nd General Assembly
A copy of an original prescription may only be filled in accordance with the rules and regulations adopted by the state board of pharmacy.
Prescriptions received electronically or by word of mouth, telephone, telegraph, or other means of communication shall be recorded in writing by the pharmacist and the record so made by the pharmacist shall constitute the original prescription to be filled by the pharmacist. All prescriptions shall be preserved on file at the pharmacy for a period of three years, subject to inspection by the proper officers of the law.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.381 | Licensed Pharmacist - Immunity.

Effective:
July 22, 1998
Latest Legislation:
Senate Bill 66 - 122nd General Assembly
No licensed pharmacist shall be liable for civil damages or in any criminal prosecution arising from the dispensing of a drug based upon a formulary established by a hospital, a health insuring corporation, a long-term care facility, or the department of rehabilitation and corrections and requiring the pharmacist to dispense the particular drug.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.391 | Adding Drug Delivery Devices to a Prescription.

Effective:
April 6, 2023
Latest Legislation:
House Bill 558 - 134th General Assembly
(A) A pharmacist may modify a drug's prescription to also include a drug delivery device, if the pharmacist determines that the device is necessary for the drug's administration.
(B) The state board of pharmacy may adopt rules to implement this section. The rules shall be adopted in accordance with Chapter 119. of the Revised Code.
(C) For purposes of reimbursement under the terms of a health benefit plan by a health care insurer, government health care program, pharmacy benefit manager, or other entity that offers health benefit plans, a prescription modified as described in this section, and in accordance with any rules adopted under it, shall be deemed a valid prescription for the drug delivery device.
Last updated March 22, 2023 at 4:52 PM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.40 | Authority for Pharmacists to Convert Prescriptions Authorizing Refills Under Certain Circumstances.

Effective:
April 6, 2017
Latest Legislation:
House Bill 285 - 131st General Assembly
(A) In the case of a prescription that authorizes a drug to be dispensed by refilling the prescription one or more times and the total quantity or amount of the drug that may be dispensed by filling and refilling the prescription does not exceed a ninety-day supply of the drug, a pharmacist who is filling or refilling the prescription may dispense a quantity or amount of the drug that varies from the quantity or amount of the drug that otherwise would be dispensed pursuant to the prescription, but only if all of the following conditions are met:
(1) The action taken by the pharmacist does not result in a quantity or amount of the drug being dispensed that exceeds the total quantity or amount that may be dispensed by filling and refilling the prescription.
(2) The prescription is for one of the following:
(a) A maintenance drug to be taken on a regular, recurring basis to treat a chronic condition;
(b) A drug to be taken on a regular, recurring basis to prevent disease;
(c) A contraceptive.
(3) If the prescription is for a maintenance drug, the patient has used an initial thirty-day supply of the drug, or a ninety-day supply of the drug has previously been prescribed to the patient, and the pharmacist determines, after consulting with the patient, that the drug has stabilized the patient's condition.
(4) The prescription is not for a controlled substance, as defined in section 3719.01 of the Revised Code.
(5) The prescriber did not include "dispense as written" or another phrase having a similar meaning on the prescription, or, when issuing a prescription electronically or orally, the prescriber did not specify that the quantity or amount of the drug to be dispensed may not vary from the quantity or amount specified in the prescription.
(6) In the exercise of the pharmacist's professional judgment after consulting with the patient, taking the action authorized by this section is appropriate for the patient.
(B) This section does not require a health care insurer, government health care program, pharmacy benefit manager, or other entity that offers health benefit plans to provide coverage for a drug in a manner that is inconsistent with the patient's benefit plan.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.42 | Authority to Order, Administer Covid-19 Diagnostic Tests.

Effective:
May 14, 2021
Latest Legislation:
House Bill 6 - 134th General Assembly
(A) A pharmacist may order and administer diagnostic tests for COVID-19 and tests for COVID-19 antibodies.
(B) Both of the following may, under the direct supervision of a pharmacist, administer diagnostic tests for COVID-19 and tests for COVID-19 antibodies:
(1) A pharmacy intern;
(2) A certified pharmacy technician.
Last updated June 3, 2021 at 10:42 AM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.43 | Delivery of Certain Non-Self-Injectable Cancer Drugs Prohibited.

Effective:
September 30, 2021
Latest Legislation:
House Bill 110 - 134th General Assembly
(A) As used in this section:
(1) "Home health agency" has the same meaning as in section 3740.01 of the Revised Code.
(2) "Hospice care program" and "hospice patient" have the same meanings as in section 3712.01 of the Revised Code.
(B) With regard to a dangerous drug that is indicated for the treatment of cancer or a cancer-related illness, must be administered intravenously or by subcutaneous injection, and cannot reasonably be self-administered by the patient to whom the drug is prescribed or by an individual assisting the patient with the self-administration, a pharmacist shall not dispense the drug by delivering the drug directly to any of the following or causing the drug to be delivered directly to any of the following:
(1) The patient;
(2) The patient's representative, which may include the patient's guardian or a family member or friend of the patient;
(3) The patient's private residence unless any of the following is the case:
(a) The patient's private residence is a nursing home, residential care facility, rehabilitation facility, or similar institutional facility or heath care facility.
(b) If the patient is an adult and a hospice patient or client of a home health agency, the patient, the licensed health professional authorized to prescribe drugs who prescribed the drug to the patient, or an employee or agent of the prescriber has notified the pharmacist that the patient is a hospice patient or client of a home health agency and an employee or agent of the hospice care program or home health agency will be administering the drug to the patient.
(c) If the patient is a minor and a hospice patient or client of a home health agency, either of the following has notified the pharmacist that the patient is a client of a home health agency and an employee or agent of the hospice care program or home health agency will be administering the drug to the patient:
(i) The licensed health professional authorized to prescribe drugs who prescribed the drug to the patient or an employee or agent of the prescriber;
(ii) The parent, guardian, or other person who has care or charge of the patient and is authorized to consent to medical treatment on behalf of the patient.
Last updated July 30, 2021 at 4:06 PM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.48 | Cost-Sharing Amount in Excess of Charge; Notice to Patient.

Effective:
October 17, 2019
Latest Legislation:
House Bill 166 - 133rd General Assembly
When filling a prescription, if a pharmacist, pharmacy intern, or terminal distributor of dangerous drugs has information indicating that the cost-sharing amount required by the patient's health benefit plan exceeds the amount that may otherwise be charged for the same drug, both of the following apply:
(A) The pharmacist, pharmacy intern, or terminal distributor shall provide this information to the patient.
(B) The patient shall not be charged the higher amount.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.49 | Terminal Distributor Contracts With 340b Program Participants.

Effective:
April 12, 2021
Latest Legislation:
Senate Bill 263 - 133rd General Assembly
(A) As used in this section, "340B covered entity, " "medicaid managed care organization, " and "third-party administrator" have the same meanings as in section 5167.01 of the Revised Code.
(B) A contract between a terminal distributor of dangerous drugs and a 340B covered entity shall require the terminal distributor to comply with division (C) of this section.
(C) When paying a 340B covered entity for a dangerous drug dispensed to a patient, a terminal distributor shall pay to the 340B covered entity the full reimbursement amount the terminal distributor receives from the patient and the patient's health insurer, including a third-party administrator or medicaid managed care organization, except that the terminal distributor may deduct from the full reimbursement amount a fee agreed on in writing by the terminal distributor and the 340B covered entity.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.50 | Contracts With Private Entities to Process Applications.

Effective:
September 29, 2011
Latest Legislation:
House Bill 153 - 129th General Assembly
(A) The state board of pharmacy may enter into contracts with private entities under which the entities process applications and renewal applications for wholesale distributors of dangerous drugs and terminal distributors of dangerous drugs. When entering into these contracts, the board shall give preference to entities that are Ohio-based companies.
Any revenue received by the board from contracts entered into under this section shall be deposited into the state treasury to the credit of the occupational licensing and regulatory fund. The money may be used for any purpose determined by the board to be relevant to its duties, including the establishment and maintenance of a drug database pursuant to section 4729.75 of the Revised Code.
(B) No enforcement or disciplinary authority granted to the board shall be transferred to a private entity through a contract entered into under this section.
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.511 | Overdose Reversal Drug Distributor; Priorities.

Effective:
September 23, 2022
Latest Legislation:
House Bill 193 - 134th General Assembly
(A) As used in this section, "overdose reversal drug distributor" means either of the following:
(1) A wholesale distributor of dangerous drugs;
(2) A terminal distributor of dangerous drugs that supplies overdose reversal drugs to any entity under division (B)(1) of this section.
(B)(1) An overdose reversal drug distributor shall prioritize the sale, distribution, and delivery of overdose reversal drugs to all of the following:
(a) A children's hospital, as defined in section 3727.01 of the Revised Code;
(b) A hospital, as defined in section 3727.01 of the Revised Code;
(c) An emergency medical service organization, as defined in section 4765.01 of the Revised Code;
(d) A facility that is operated as an urgent care center.
(2) The order in which the entities are listed in division (B)(1) of this section does not establish levels of priority among the listed entities.
(C) An overdose reversal drug distributor who in good faith complies with division (B) of this section is not liable for or subject to any of the following for an act or omission arising from that compliance: damages in any civil action, prosecution in any criminal proceeding, or professional disciplinary action.
Last updated October 19, 2022 at 1:23 PM
2023 Ohio Revised Code › Title 47 | Occupations-Professions › Chapter 4729 | Pharmacists; Dangerous Drugs › Section 4729.513 | Donation of Inhalers and Epinephrine Autoinjectors.

Effective:
April 12, 2021
Latest Legislation:
House Bill 231 - 133rd General Assembly
A manufacturer of dangerous drugs may donate inhalers, as defined in section 3313.7113 of the Revised Code, epinephrine autoinjectors, or injectable or nasally administered glucagon to any of the following:
(A) The board of education of a city, local, exempted village, or joint vocational school district;
(B) A community school established under Chapter 3314. of the Revised Code;
(C) A STEM school established under Chapter 3326. of the Revised Code;
(D) A college-preparatory boarding school established under Chapter 3328. of the Revised Code;
(E) A chartered or nonchartered nonpublic school;
(F) A residential camp, as defined in section 2151.011 of the Revised Code;
(G) A child day camp, as defined in section 5104.01 of the Revised Code;
(H) A child day camp operated by any county, township, municipal corporation, township park district created under section 511.18 of the Revised Code, park district created under section 1545.04 of the Revised Code, or joint recreation district established under section 755.14 of the Revised Code.